Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs US Bancorp (USB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE HealthCare Technologies Inc. Common Stock vs US Bancorp — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $68.5 (market cap $31.07B), while US Bancorp trades at $56.21 (market cap $88.64B). The key difference: US Bancorp is far larger — about 2.9× GE HealthCare Technologies Inc. Common Stock's market cap, and US Bancorp pays the higher dividend (3.8%). Which is the better fit depends on your goals.
| GEHC | USB | |
|---|---|---|
Market Cap | $31.07B | $88.64B |
Volume | 3,443,020 | 8,200,583 |
Sector | Health | Financials |
52-Week High | $88.16 | $65.42 |
52-Week Low | $59.48 | $45.47 |
Enterprise Value | $39.53B | $118.14B |
Dividend Yield | 0.23% | 3.8% |
Typical Hold Time | — | 98 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
U.S. Bancorp (USB) trades at $56.26, down 2.02% today, with a bearish technical signal from moving averages. The company shows strong fundamentals with a P/E of 11.36 and net income margin of 27.61%, having beaten earnings estimates for three consecutive quarters. Recent news highlights dividend increases and strong Q3 expectations, while analyst consensus remains positive with a $69.94 price target.
USB presents a value opportunity with attractive valuation metrics and consistent earnings outperformance, though near-term technical weakness and regulatory uncertainties pose risks. The stock's 3.8% dividend increase signals management confidence, but investors should monitor interest rate sensitivity and competitive pressures in the banking sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →About US Bancorp
As a diversified financial-services provider, U.S. Bancorp is one of the nation's largest regional banks, with branches in well over 20 states, primarily in the Western and Midwestern United States. The bank offers many services, including retail banking, commercial banking, trust and wealth services, credit cards, mortgages, and other payments capabilities.
Read more on USB →
